Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis

Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysis

The efficacy of immune checkpoint inhibitors (ICIs) on KRAS-mutant advanced non-small cell lung cancer (NSCLC) remains controversial. This retrospective study compared the effects of ICIs treatment and chemotherapy on the prognosis of patients with KRAS-mutant advanced NSCLC and different mutant sub...

Full description

Bibliographic Details
Main Authors: Gu Xiaodong, Si Jinfei, Guan Yelan, Xu Yibing, Shao Lan, Zhang Yiping, Xu Chunwei, Pan Weiwei, Lu Yuanzhi, Song Zhengbo, Wang Wenxian
Format: Article
Language:English
Published: De Gruyter 2023-03-01
Series:Open Medicine
Subjects:
kras
nsclc
icis
chemotherapy
kras g12c
Online Access:https://doi.org/10.1515/med-2023-0653

Similar Items

Similar Items